Pillstats
Rx only · Tablet · Oral

Glycopyrrolate

Brands: Glycate · Glycopyrrolate

21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US48 NDCs
21 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD11AA01
RxCUI (US)1546438
US makers21 labelers
Packages81
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 19 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.047$0.094$0.141$0.188Dec 2025Apr 2026Jul 2026
$0.120
Latest avg · Jul 22, 2026
-26%
Since Dec 17, 2025
21
Active US suppliers
56%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

36K73K109K146K2025 Q12025 Q22025 Q32025 Q42026 Q1
111K
Rx · 2026 Q1
8.4M
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it21 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager41SUPPLYING
Rising Pharma Holdings, Inc.unknown4SUPPLYING
Dr.Reddy's laboratories Limitedunknown4SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
QUAGEN PHARMACEUTICALS LLCunknown4SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
Quinn Pharmaceuticalsunknown2SUPPLYING
Leading Pharma, LLCunknown2SUPPLYING
Alembic Labs LLCunknown2SUPPLYING
Florida Pharmaceutical Products, LLCunknown2SUPPLYING
Aurolife Pharma, LLCunknown2SUPPLYING
Endo USA, Inc.unknown2SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown2SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown1SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING

+ 6 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 18, 2023
    RECALLRecall (Class III): Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor…

    Failed Impurities/Degradation Specifications — Recalling firm: Aurolife Pharma, LLC — Nationwide within the United States

  • Dec 22, 2022
    RECALLRecall (Class II): Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton, Rx Only, Manufactured for: AvKARE Pulaski, TN 38…

    Failed impurities/degradation specifications: Out of specification for unknown impurities. — Recalling firm: AVKARE LLC — USA Nationwide

  • Dec 16, 2022
    RECALLRecall (Class II): Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 0…

    Failed Impurities/Degradation Specifications — Recalling firm: Aurolife Pharma, LLC — Nationwide in the USA and Puerto Rico.

  • Mar 17, 2022
    RECALLRecall (Class II): Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton…

    Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room. — Recalling firm: Aurolife Pharma, LLC — Nationwide in the USA and Puerto Rico